ArticleJournal of medicinal chemistry2022

Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH Dehydrogenases.

Sushovan Dam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.